Titlebook: Breast Cancer Treatment: An Interdisciplinary Approach; Nima Rezaei Book 2024 The Editor(s) (if applicable) and The Author(s), under exclu

淹没

书目名称Breast Cancer Treatment: An Interdisciplinary Approach影响因子(影响力)




书目名称Breast Cancer Treatment: An Interdisciplinary Approach影响因子(影响力)学科排名




书目名称Breast Cancer Treatment: An Interdisciplinary Approach网络公开度




书目名称Breast Cancer Treatment: An Interdisciplinary Approach网络公开度学科排名




书目名称Breast Cancer Treatment: An Interdisciplinary Approach被引频次




书目名称Breast Cancer Treatment: An Interdisciplinary Approach被引频次学科排名




书目名称Breast Cancer Treatment: An Interdisciplinary Approach年度引用




书目名称Breast Cancer Treatment: An Interdisciplinary Approach年度引用学科排名




书目名称Breast Cancer Treatment: An Interdisciplinary Approach读者反馈




书目名称Breast Cancer Treatment: An Interdisciplinary Approach读者反馈学科排名

馆长

Triple-Negative Breast Cancer Therapy: Recent Advances, Challenges, and Future Perspective,d therapy for TNBC is challenging. Chemotherapy, radiation therapy, and surgical resection are the existing treatment options for TNBC. Chemotherapy is sensitive to TNBC; however, development of resistance mechanisms and recurrence remain the major reasons of treatment failure in patient with TNBC.

Estrogen

Advances in Local Ablative Techniques for Breast Cancer,ant mastectomies, which often led to significant physical and psychological morbidity, the focus has shifted to breast-conserving surgery and minimally invasive ablative techniques..This chapter provides a comprehensive review of the various ablative modalities available for breast cancer management

多产鱼

流利圆滑

podiatrist

Insufficient

Updates on the Management of Ductal Carcinoma In Situ of the Breasts,rement. Adjuvant radiotherapy is usually advised in patients who received lumpectomy. However, over the last decades, de-escalating DCIS treatment has been a debatable topic. Ongoing randomized controlled trials (RCTs) are now in progress to evaluate whether or not we could safely omit surgery in se

预测

Nanostructured Lipid Carrier as a Strategy for the Treatment of Breast Cancer,of deaths annually worldwide. Conventional treatment, although clinically effective, is associated with the development of resistance in more advanced stages of the disease and high toxicity in healthy cells, leading to a poor prognosis. Furthermore, the active compounds that represent these therape

真繁荣

Managing Breast Cancer Using the Cell-Surface GRP78,tment of breast cancer, there is a need for more effective management strategies..Different avenues emerged recently use the glucose-regulated protein 78 (GRP78) in cancer patients both in diagnosis and in treatment. In addition to managing the unfolded protein response under the stress of the unfol

繁重